EMAIL: [email protected]
PHONE: 720.643.4450

Kristen Nichols

Kristen is a Denver-based reporter for Marijuana Business Daily specializing in the hemp and CBD industries. Previously, she worked at the Associated Press for nearly 20 years. She started covering the marijuana legalization movement in 2009 – when medical stores started popping up around Denver – and wrote about the state’s first legal hemp harvest. Kristen also covered agriculture and politics in Maryland and her home state of Georgia.


Hemp importers see victory in legal setback against US Customs

A California court is giving hemp and CBD importers reason to smile, even though a federal judge dismissed most of a CBD company’s legal challenge to U.S. Customs and Border Protection. In his decision, U.S. District Judge Jesus Bernal repeatedly said the 2018 Farm Bill makes clear that hemp shipments shouldn’t be considered marijuana nor destroyed. […]

Read More

Texas loosens state-level hemp ban, but uncertainty remains

Hemp holdout Texas is taking a big step toward embracing the federally legal plant, with one agency announcing a rule change to remove the plant from the state’s definition of marijuana. But entrepreneurs hoping that Texas will allow a hemp industry before federal agencies take action say that the April 5 change isn’t enough to […]

Read More

Maine authorizes CBD foods after unpopular crackdown

Maine has changed course on CBD foods less than three months after health authorities ordered CBD foods off shelves. A new law gives CBD manufacturers express permission to add cannabidiol to foods in contravention of federal law, which bans the addition of CBD into the food supply. Gov. Janet Mills signed the CBD food law […]

Read More

CV Sciences earnings rise, but CEO says CBD confusion limiting growth

(This story has been updated to clarify that the CEO referred to state regulatory differences on CBD, not seizures of CBD.) CBD giant CV Sciences posted $10.2 million in profit last year, a big improvement from 2017, when the company lost roughly $4.9 million, according to the firm’s year-end fiscal report. The San Diego company, which […]

Read More

Report: FDA chief to resign, leaving CBD review in question

Just as the CBD industry was hoping to start work next month on the cannabinoid’s place in food, drugs and cosmetics, the head of the U.S. Food and Drug Administration chief is resigning. Dr. Scott Gottlieb, who told Congress last week that CBD can’t be added to consumer products, is leaving office in April, according […]

Read More

USDA plans webinar on hemp and the Farm Bill, invites comments

The U.S. Department of Agriculture (USDA) will hold a webinar to get public input on the 2018 Farm Bill and hemp production. All interested parties are welcome to provide comments during the March 13 session, hosted by the USDA’s Specialty Crops Program. Participants must register in advance, and those who wish to speak must submit written comments to [email protected] by […]

Read More

Earnings roundup: GW Pharmaceuticals awaiting big CBD drug sales as it reports losses

GW Pharmaceuticals, the drugmaker behind the only federally approved CBD product, is still losing money, though it says it’s happy with early sales of its seizure control drug Epidiolex. Last summer, Epidiolex became the first cannabis-derived treatment approved by the U.S. Food and Drug Administration, prompting the U.S. Drug Enforcement Administration to reschedule CBD under […]

Read More

North Dakota court says CBD status not a ‘matter of great public concern’

North Dakota’s highest court has decided not to rule on the legality of hemp-derived CBD, upholding a drug conviction for a vape-shop owner who sold CBD. The court said that the retailer, Falesteni A. Abu Hamda, should have made his CBD argument earlier instead of accepting the state’s case against him. Hamda was charged with seven drug […]

Read More